Health & Fitness
Health and Fitness
Health and Fitness
Mon, August 13, 2012
Fri, August 10, 2012
NxStage to Present at the Canaccord Genuity 32nd Annual Growth Conference
NxStage to Present at the Canaccord Genuity 32nd Annual Growth Conference -- LAWRENCE, Mass., Aug. 10, 2012 /PRNewswire/ --
NxStage to Present at the Canaccord Genuity 32nd Annual Growth Conference
LAWRENCE, Mass., Aug. 10, 2012 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: [ NXTM ]), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer, will present at the Canaccord Genuity 32nd Annual Growth Conference on Tuesday, August 14th, at 4:30 p.m. ET. A webcast of the event will be made available at [ http://ir.nxstage.com/ ] at the time of the presentation.
(Logo: [ http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ] )
About NxStage Medical
NxStage Medical, Inc. (Nasdaq: [ NXTM ]) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company's website at [ http://www.nxstage.com ].
Forward-Looking Statements
This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Examples of these forward-looking statements include statements as to Mr. Burbank's plans to present at this conference. NxStage specifically disclaims any obligation to update these forward-looking statements. These forward-looking statements should not be relied upon as representing NxStage's expectations or beliefs as of any date subsequent to the date of this press release.
Contact:
Kristen K. Sheppard, Esq.
Investor Relations
[ ksheppard@nxstage.com ]
SOURCE NxStage Medical, Inc.
[ Back to top ]
RELATED LINKS
[ http://www.nxstage.com ]
